title: Intensive therapy for myeloma.
authors.affiliation: Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
authors.forename: T J
authors.initials: TJ
authors.lastname: McElwain
authors.forename: M
authors.initials: M
authors.lastname: Meldrum
authors.forename: M E
authors.initials: ME
authors.lastname: Gore
authors.forename: B C
authors.initials: BC
authors.lastname: Millar
authors.forename: J S
authors.initials: JS
authors.lastname: Malpas
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000601:surgery; D011239:Prednisolone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D011239:Prednisolone; D001379:Azathioprine; D008558:Melphalan; D008775:Methylprednisolone; D008727:Methotrexate